8.60
11.40%
0.88
시간 외 거래:
8.56
-0.04
-0.47%
Emergent Biosolutions Inc 주식(EBS)의 최신 뉴스
Insider Sale: Director Donald Degolyer Sells 25,000 Shares of Em - GuruFocus.com
Emergent BioSolutions director Donald DeGolyer sells $272,750 in stock - Investing.com
Emergent BioSolutions director Donald DeGolyer sells $272,750 in stock By Investing.com - Investing.com UK
Oak Hill Advisors LP's Strategic Acquisition of Emergent BioSolu - GuruFocus.com
Insider Sale: Director Marvin White Sells 14,287 Shares of Emergent BioSolutions Inc (EBS) - GuruFocus.com
Smallpox Treatment Market Is Anticipated To Grow In A Promising - openPR
Emergent BioSolutions Inc (EBS) Shares Down 8.02% on Nov 12 - GuruFocus.com
IDWeek 2024: strategic approaches and challenges in mpox vaccination - Pharmaceutical Technology
Emergent BioSolutions Inc. (NYSE:EBS) Q3 2024 Earnings Call Transcript - MSN
Emergent BioSolutions Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Emergent BioSolutions (NYSE:EBS) Shares Up 7.9% After Analyst Upgrade - MarketBeat
Emergent BioSolutions Inc (EBS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
Emergent BioSolutions: Stock Surging Post Q3 Earnings Thanks To Papa Magic (NYSE:EBS) - Seeking Alpha
Emergent Biosolutions Stock Soars After Q3 Earnings: Retail Sentiment Strong - MSN
Overdose Crisis In Shadows Of Elections As Black, Indigenous Americans Deaths Rise - Benzinga
Emergent BioSolutions Inc (EBS) Quarterly 10-Q Report - Quartzy
Emergent BioSolutions entering ‘turnaround’ phase, new CEO says - The Business Journals
Mpox Vaccine Player Emergent BioSolutions Stock Jumps On Upbeat Annual Forecast, Expects Smaller Losses In 2024 - Yahoo Finance
Crude Oil Rises 1%; US Jobless Claims Increase To 221,000 - Benzinga
Emergent BioSolutions (NYSE:EBS) Shares Gap Up on Analyst Upgrade - MarketBeat
Emergent Biosolutions Shares Surge 28% After Swinging to 3Q Profit - MarketWatch
Emergent BioSolutions stock target increased, keeps buy on strong Q3 By Investing.com - Investing.com UK
The Post-Trump Victory TradeEmergent BioSolutions (NYSE:EBS), Bit Digital (NASDAQ:BTBT) - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Emergent Biosolutions: Q3 Earnings Snapshot - Houston Chronicle
Emergent BioSolutions (EBS) Q3 2024 Earnings Call Transcript - AOL
Emergent Biosolutions (EBS) Q3 Earnings Beat Estimates - Yahoo Finance
Emergent Biosolutions stock jumps 14% post-market on guidance raise (NYSE:EBS) - Seeking Alpha
Emergent BioSolutions Supports New Clinical Trial Evaluating the Safety and Efficacy of Brincidofovir in Treating Mpox Virus Across Africa - The Manila Times
The Escalator: Emergent BioSolutions, CureVac, Kyowa Kirin and more - MM+M Online
Emergent BioSolutions Reports Third Quarter 2024 Financial Results - The Manila Times
Emergent BioSolutions Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Emergent Bio slips after financing deal - MSN
Emergent BioSolutions appoints new chief medical officer By Investing.com - Investing.com Canada
Biotech Co. Emergent Gives Interim GC Permanent Role - Law360
Emergent BioSolutions appoints new chief medical officer - Investing.com
Emergent BioSolutions (EBS) Scheduled to Post Quarterly Earnings on Wednesday - MarketBeat
Emergent Bio's smallpox vaccine gets US approval for mpox - AOL
Assenagon Asset Management S.A. Increases Stock Position in Emergent BioSolutions Inc. (NYSE:EBS) - MarketBeat
Is Emergent BioSolutions (NYSE:EBS) Using Debt In A Risky Way? - Simply Wall St
Zacks.com featured highlights include American Airlines, Air Canada, EmergentBioSolutions, Berry and Cracker Barrel Old Country Store - Yahoo Finance
5 Broker Liked Stocks to Keep an Eye on After Recent Analyst Upgrades - Yahoo Finance
Pomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Emergent BioSolutions Inc. Common Stock - GlobeNewswire Inc.
Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference Call on November 6, 2024 - The Manila Times
Emergent BioSolutions to Release Third Quarter 2024 Financial Results and Conduct Conference - The Bakersfield Californian
Emergent BioSolutions (NYSE:EBS) Shares Up 3.2%Here's What Happened - MarketBeat
Biopharma Layoffs Roundup - Contract Pharma
Zacks.com featured highlights include Grupo Supervielle, Emergent BioSolutions and Innodata - Yahoo Finance
3 Stocks Poised for Better Returns With New Analyst Coverage - Yahoo Finance
Emergent BioSolutions Inc. (NYSE:EBS) Short Interest Up 84.1% in September - MarketBeat
Emergent BioSolutions Inc. (NYSE:EBS) Shares Sold by Dimensional Fund Advisors LP - MarketBeat
Emergent BioSolutions Inc. (EBS): A Standout Among Best Performing Cheap Stocks in 2024 - Insider Monkey
Emergent BioSolutions Inc (EBS) Q2 2024 Earnings Call Highlights: Navigating Challenges and Seizing Opportunities - GuruFocus.com
자본화:
|
볼륨(24시간):